The DOI matches its Crossref record; 313 of the 318 references it cites were found in a registry or an index; none of the 336 sources its claims cite is checked for support yet.
ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies
Open accessAbstract
Enzymes catalyze biochemical reactions and play critical roles in human health and disease. Enzyme variants and deficiencies can lead to variable expression of glycans, which can affect physiology, influence predilection for disease, and/or directly contribute to disease pathogenesis. Although certain well-characterized enzyme deficiencies result in overt disease, some of the most common enzyme deficiencies in humans form the basis of blood groups. These carbohydrate blood groups impact fundamental areas of clinical medicine, including the risk of infection and severity of infectious disease, bleeding risk, transfusion medicine, and tissue/organ transplantation. In this review, we examine the enzymes responsible for carbohydrate-based blood group antigen biosynthesis and their expression within the human population. We also consider the evolutionary selective pressures, e.g. malaria, that may account for the variation in carbohydrate structures and the implications of this biology for human disease.
Overview
CoChat Summary
TL;DR
This review synthesizes carbohydrate-based blood group systems and common human enzyme deficiencies, emphasizing how ABO(H), Lewis, I, Globoside/P1PK, FORS, and SID antigens arise from glycosyltransferase variation and affect transfusion, transplantation, infection, and thrombosis. It argues that common enzyme deficiencies, especially blood group O and FUT2 non-secretor status, reflect evolutionary trade-offs with pathogens such as *Plasmodium falciparum* and cholera.
Key findings
- The review covers eight carbohydrate-based blood group systems (H, ABO, Lewis, I, Globoside, P1PK, FORS, SID) and notes that blood group O results from deficiency of A and B glycosyltransferases; blood group O is estimated at ≥30% of the world population (≥2.4 billion), with regional prevalence from 29% in India to 80% in parts of Central and South America.
- Blood group O is associated with protection against severe *P. falciparum* malaria but increased severe cholera and 20%–30% lower von Willebrand factor and factor VIII levels (∼25% less vWF/FVIII); non-secretors (FUT2 deficiency, about 20%–25% globally) have resistance to norovirus, rotavirus, and *H. pylori*, with one cited case-control study reporting 98% protection against severe rotavirus gastroenteritis.
- Other common enzyme deficiencies reviewed include G6PD deficiency (∼500 million people, 6.3%), ALDH2 deficiency (∼8% of the world population), NAT2 slow acetylators (>50%), lactase deficiency (∼65% or 5.1 billion), CYP3A5 intermediate/poor metabolizers (>75%), caspase 12 deficiency (>95%), Forssman synthase deficiency (99.99%), and CMAH/GGTA1 deficiency (100%).
- ABO(H) antibodies are naturally occurring, can cause acute hemolytic transfusion reactions, hemolytic disease of the fetus/newborn, and graft rejection; ABO-incompatible transplantation often requires anti-ABO(H) titers ≤1:8, and enzymatic conversion of A RBCs to O (ECO-RBCs) remains limited by incomplete/inefficient reactions, agglutination, and cost.
Methods
- Design: narrative review; the authors state they examine the enzymes responsible for carbohydrate-based blood group antigen biosynthesis, their expression in the human population, and evolutionary selective pressures such as malaria.
- Data/sample: no primary cohort; evidence is drawn from cited literature, ISBT/ClinVar/OMIM allele tables, GWAS/meta-analyses, and prevalence studies, with tables summarizing blood group systems, selected rsIDs, phenotypes, and common enzyme deficiencies.
- Main analysis: qualitative synthesis of biosynthesis, anti-carbohydrate antibodies, prevalence, evolution/health implications, and a proposed perspective on common human enzyme deficiencies; no systematic search or meta-analysis is described.
Limitations
- Stated: the review does not cover all enzyme deficiencies affecting glycan structure; the authors could not evaluate all enzymes and could not always obtain estimated global prevalence for enzyme-deficiency phenotypes; they note a lack of consensus on the most common human enzyme deficiency.
- Stated: race is recognized as a social construct, and reported blood group distributions likely reflect ancestry and selection patterns but may not be attributable to race as defined in each cited study.
- Evident: as a narrative review, it relies on heterogeneous cited studies and does not perform systematic screening or quantitative pooling; some cited associations (e.g., ABO and COVID-19 severity) are described as conflicting or not definitively determined.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
0 Valid · 5 Not valid · 232 Not checked · 52 Own results and interpretations
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These carbohydrate blood groups impact fundamental areas of clinical medicine, including the risk of infection and severity of infectious disease, bleeding risk, transfusion medicine, and tissue/organ transplantation.”
§ ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These carbohydrate blood groups impact fundamental areas of clinical medicine, including the risk of infection and severity of infectious disease, bleeding risk, transfusion medicine, and tissue/organ transplantation.”
§ ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Enzyme variants and deficiencies can lead to variable expression of glycans, which can affect physiology, influence predilection for disease, and/or directly contribute to disease pathogenesis.”
§ ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies > Abstract
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A statement the paper makes itself — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Enzyme variants and deficiencies can lead to variable expression of glycans, which can affect physiology, influence predilection for disease, and/or directly contribute to disease pathogenesis.”
§ ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Enzyme variants and deficiencies can lead to variable expression of glycans, which can affect physiology, influence predilection for disease, and/or directly contribute to disease pathogenesis.”
§ ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
132 more claims
Create a free account to see all 289 claims and to verify the 287 references still open.
- Probably not a substantial claim. 90
- It may state two separate claims as one. 93
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies > Common human enzyme deficiencies
“Forssman synthase deficiency (FORS1 antigen negative) | 0% | Pseudogene, until activating mutations discovered | Possible ↑ resistance to Shiga toxin | Possible ↑ susceptibility to E. coli”
§ ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies > FORS blood group system > Evolution and health
“P-fimbriated strains of E. coli can bind to FORS1, which may increase susceptibility to infection. In contrast, FORS1 expressing cells are less susceptible to Shiga toxin (Cohn et al., 2020; Hult and Olsson, 2017).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies > Introduction
“The alpha anomer refers to the configuration where the hydroxyl attached to the anomeric carbon is on the opposite face of the ring compared with the substituent on the other carbon flanking the ring oxygen.”
§ ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies > Introduction
“In contrast, if these two substituents are on opposite faces of the ring, this is called the beta anomer.”
Citations
Cites
Wiederschain, G. Y. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909090156 · Cited by 4,083
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635 · cited 2×
“Glycosylation depends on the cell’s repertoire of glycosyltransferases, their localization in the cell, nucleotide sugar donor’s requisite to their synthesis, the final destination of the glycoprotein or lipid, as well as the actions of degradative glycosidases that trim glycans (Varki, 2017).”
BackgroundGenomewide Association Study of Severe Covid-19 with Respiratory Failure
The Severe Covid-19 GWAS Group (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2020283 · Cited by 1,980
Glucose-6-phosphate dehydrogenase deficiency
Cappellini, M., & Fiorelli, G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60073-2 · Cited by 1,590
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809329 · Cited by 1,577
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
Chung, C. H., Mirakhur, B., Chan, E., Le, Q.-T., Berlin, J., Morse, M., Murphy, B. A., Satinover, S. M., Hosen, J., Mauro, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074943 · Cited by 1,521
Smedley, A., & Smedley, B. D. (2005) · American Psychologist · doi:10.1037/0003-066x.60.1.16 · Cited by 1,265
Caspases in Cell Death, Inflammation, and Disease
Van Opdenbosch, N., & Lamkanfi, M. (2019) · Immunity · doi:10.1016/j.immuni.2019.05.020 · Cited by 1,220
Molecular genetic basis of the histo-blood group ABO system
Yamamoto, F.-I., Clausen, H., White, T., Marken, J., & Hakomori, S.-I. (1990) · Nature · doi:10.1038/345229a0 · Cited by 1,181
How Malaria Has Affected the Human Genome and What Human Genetics Can Teach Us about Malaria
Kwiatkowski, D. P. (2005) · The American Journal of Human Genetics · doi:10.1086/432519 · Cited by 1,104
Research works printed but not linked: 4
- F S, 1934, Zur Kenntnis der Blutantigene des Shigabacillus, Z. Immunitatsforsch., 82
- Bernstein, 1925, Zusammenfassende Beobachtungen uber die erblichen Blutstructuren des Menschen, Z. Indukt. Abstammungs Vererbungsl., 37, 237
- Hollenhorst, 2022, Comprehensive analysis of platelet glycoprotein Iba glycosylation, bioRxiv
- Landsteiner, 1900, Zur Kenntnis der antifermativen, lytischen und agglutinierenden Wirkungendes Blutserums und der Lymphe. Zentbl. Bakt. Parasitkde, Abt., 27, 357
Cited by
Carbohydrate-active enzymes from Akkermansia muciniphila break down mucin O-glycans to completion
Bakshani, C. R., Ojuri, T. O., Pilgaard, B., Holck, J., McInnes, R. S., Kozak, R. P., Zakhour, M. I., Çakaj, S., Kerouedan, M., Newton, E., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-024-01911-7 · Cited by 107
Biochemical and structural basis of sialic acid utilization by gut microbes
Bell, A., Severi, E., Owen, C. D., Latousakis, D., & Juge, N. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.102989 · Cited by 83
Genetics of glycosylation in mammalian development and disease
Stanley, P. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-024-00725-x · Cited by 54
Reading and Writing the Human Glycocode
de Haan, N., Nielsen, M. I., & Wandall, H. H. (2024) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-030122-044347 · Cited by 36
Crouch, L. I., Rodrigues, C. S., Bakshani, C. R., Tavares-Gomes, L., Gaifem, J., & Pinho, S. S. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2024.101891 · Cited by 31
Metadata
- Authors
- Jajosky, R. P., Wu, S.-C., Zheng, L., Jajosky, A. N., Jajosky, P. G., Josephson, C. D., Hollenhorst, M. A., Sackstein, R., Cummings, R. D., Arthur, C. M., & Stowell, S. R.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Rochester Medicine (US)
- Johns Hopkins University (US)
- Stanford Medicine (US)
- Florida International University (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Stowell, Sean R.
- ORCID
- Venue
- iScience
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 26
- Issue
- 1
- Pages
- 105798
- ISSN
- 2589-0042 (ISSN-L)
- PMC
- PMC9860303
- OpenAlex
- W4311301885
- Cited by
- 110
- References
- 318
- Citations by year
- 2026: 39 · 2025: 35 · 2024: 23 · 2023: 13
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- iScience (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (DP5 OD019892, U01CA242109)
- Burroughs Wellcome Fund (R01 HL138714, R01 HL154034, R24GM137763)
- National Blood Foundation (1K99HL156029-01)
- Topics
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Keywords
- ABO blood group system, blood group antigens, glycan expression, enzyme deficiency, glycosyltransferases, malaria, transfusion medicine, organ transplantation, infection risk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies. https://app.cochat.ai/papers/10.1016/j.isci.2022.105798
- The paper
- Jajosky, R. P., Wu, S.-C., Zheng, L., Jajosky, A. N., Jajosky, P. G., Josephson, C. D., Hollenhorst, M. A., Sackstein, R., Cummings, R. D., Arthur, C. M., & Stowell, S. R. (2023). ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies. iScience. https://doi.org/10.1016/j.isci.2022.105798
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.